LON:THRL Target Healthcare REIT (THRL) Share Price, News & Analysis GBX 97 +0.80 (+0.83%) As of 08/22/2025 12:32 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock About Target Healthcare REIT Stock (LON:THRL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Target Healthcare REIT alerts:Sign Up Key Stats Today's Range 95.60▼ 9950-Day Range 96▼ 105.4052-Week Range 78.77▼ 107Volume2.53 million shsAverage Volume2.03 million shsMarket Capitalization£593.74 millionP/E Ratio8.13Dividend Yield6.19%Price TargetN/AConsensus RatingN/A Company Overview Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes. Read More Receive THRL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Target Healthcare REIT and its competitors with MarketBeat's FREE daily newsletter. Email Address THRL Stock News HeadlinesTarget Healthcare optimistic on "consistent" returns in 2025August 7, 2025 | lse.co.ukTarget Healthcare REIT: Strong Rent Collection and Inflation Links Underpin GrowthJune 12, 2025 | uk.investing.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. | Brownstone Research (Ad)Target Healthcare touts outperformance in third quarter; ups dividendMay 9, 2025 | lse.co.ukPutting £450 in the stock market each month could be worth this much in a decadeApril 29, 2025 | msn.com1AHR : What Analysts Are Saying About American Healthcare REIT StockApril 28, 2025 | benzinga.comAre REITs the best UK dividend shares on the stock market to consider right now?April 22, 2025 | msn.comHalf Year 2025 Target Healthcare REIT PLC Investor Presentation TranscriptApril 3, 2025 | gurufocus.comSee More Headlines THRL Stock Analysis - Frequently Asked Questions How have THRL shares performed this year? Target Healthcare REIT's stock was trading at GBX 83.99 at the beginning of 2025. Since then, THRL shares have increased by 15.5% and is now trading at GBX 97. How were Target Healthcare REIT's earnings last quarter? Target Healthcare REIT (LON:THRL) issued its earnings results on Friday, March, 14th. The company reported $3.06 earnings per share for the quarter. Target Healthcare REIT had a trailing twelve-month return on equity of 10.78% and a net margin of 104.99%. Read the conference call transcript. How do I buy shares of Target Healthcare REIT? Shares of THRL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Target Healthcare REIT own? Based on aggregate information from My MarketBeat watchlists, some other companies that Target Healthcare REIT investors own include Realty Income (O), AT&T (T), Cambian Group (CMBN), Meta Platforms (META), Pfizer (PFE), Primary Health Properties (PHP) and Aviva (AV). Company Calendar Last Earnings3/14/2025Today8/23/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorReal Estate Industry REIT - Healthcare Facilities Sub-IndustryN/A Current SymbolLON:THRL CIKN/A Webwww.targethealthcarereit.co.uk Phone+44-131-6252951FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 11.93 Trailing P/E Ratio8.13 Forward P/E Ratio15.59 P/E Growth1.48Net Income£72.07 million Net Margins104.99% Pretax MarginN/A Return on Equity10.78% Return on Assets3.86% Debt Debt-to-Equity Ratio34.92 Current Ratio7.20 Quick Ratio1.52 Sales & Book Value Annual Sales£68.64 million Price / Sales8.65 Cash FlowGBX 6.75 per share Price / Cash Flow14.37 Book ValueGBX 111.13 per share Price / Book0.87Miscellaneous Outstanding Shares612,105,168Free FloatN/AMarket Cap£593.74 million OptionableNot Optionable Beta0.44 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:THRL) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Target Healthcare REIT Please log in to your account or sign up in order to add this asset to your watchlist. Share Target Healthcare REIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.